Dynamitepennystocks.com Investing Watchlist: Snts, Bsdm, Xsel - Afternoon Market Gainers

Online, September 8, 2010 (Newswire.com) - DynamitePennyStocks primary focus is to alert our valued subscribers to small cap and microcap companies poised for explosive movement in the market. As every investor knows, timing in the market is critical! To receive our FREE comprehensive newsletter, please visit www.dynamitepennystocks.com and join us on Twitter

Santarus Inc. (NASDAQ: SNTS), is a specialty pharmaceutical company that focuses on acquiring, developing and commercializing proprietary products that help patients who are treated by gastroenterologists. SNTS opened this morning at $2.37 and is now currently trading at $2.67 for an afternoon gain of ($0.45, 20.3%). Yesterday they announced that they entered into a distribution and license agreement granting them exclusive rights to manufacture and commercialize Cycloset tablets in the U.S.

BSD Medical Corp. (NASDAQ: BSDM), has been trading between the range of $2.30 and $2.72 and is now sitting at $2.63 for an impressive increase of over 16%. BSDM develops and manufactures medical systems that deliver precision-focused radio frequency energy into diseased sites of the body. Today the company announced that Dalian Orientech Co., the company's exclusive China distributor, has ordered two BSD-2000 Hyperthermia Systems.

Xinhua Sports & Entertainment Ltd. (NASDAQ: XSEL), is a leading sports and entertainment media company in China. XSEL's unique abilities include international sports programming and high profile entertainment content. The stock saw a huge gain today as they have hit their all day high of $0.022 for an increase of ($0.005, 29.4%).

Disclosure
DynamitePennyStocks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. DynamitePennyStocks.com is a wholly owned entity of a financial public relations firm. Please read our report and visit our website, for complete risks and disclosures.